Zurich (awp) – The Swiss Stock Exchange had a positive start to the session on Tuesday, notwithstanding scrambled signals from across the Atlantic. The New York indices were indeed scattered for their first session of the week, the Dow Jones dropping 0.13% while the Nasdaq gained 0.60%.
The decline of the Dow Jones betrays a crystallization of investor interest in the tech segment alone, observes Ipek Ozkardeskaya, analyst at Swissquote.
On the economic front, Swiss foreign trade generated a surplus of nearly 6 billion Swiss francs in October. Watch exports, on the other hand, experienced another month of decline. Also on the program is inflation in the euro zone over the same period, then indicators on the real estate market in Uncle Sam’s country.
But it was Nestlé that observers’ attention was focused on. The Vevey giant has delivered the broad outlines of its new strategy, a month and a half after the unexpected departure of its former boss Mark Schneider.
At 9:10 a.m., the Swiss Market Index (SMI) rose by 0.26% to 11,672.49 points, the Swiss Leader Index (SLI) by 0.28% to 1919.25 points and the Swiss Performance Index (SPI ) by 0.22% to 15,526.83 points. Of the thirty main valuations, twenty advanced, eight declined and both Lindt and Richemont were still hesitant about the direction to adopt.
The food liner Nestlé (+0.3%) was letting itself be carried away, after having come up with a new roadmap in the more or less short term under the leadership of its new helmsman Laurent Freixe. The multinational is also preparing the ground for outsourcing problematic activities in water and other beverages.
Sonova (-2.0%) inherited the red lantern without any possible dispute. The hearing specialist published a disappointing half-year performance in terms of profitability, hoping to turn things around in the second half of the year.
Pharmaceutical heavyweights Roche (-0.1%) and Novartis (+0.3%) followed opposite trajectories.
The carrier Swatch (+0.2%) ignored the decline in watch exports.
On the broader market, the automotive subcontractor Autoneum (+1.4%) takes orders from its Chinese counterpart Jiangsu Huanyu, for 75 million Swiss francs.
The pharmaceutical industry supplier Siegfried (+1.3%) inaugurated its new research center in Valais, creating around 100 jobs.
Bone substitute developer Kuros (+7.0%) is launching into extremities, in addition to its existing activities around the spine.
jh/rr
